Sign up to our newsletter
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
LATEST ALERTS
View all Cannabis and cannabinoids in Ireland
News analysis
Global business and regulatory news covering the cannabis industry
New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
Daily news alerts
Daily regulatory updates of legal changes in the cannabis sector, including monthly compilations
13th November 2023
Ireland: A motion to decriminalise the possession of small quantities of cannabis was rejected this weekend at the left-wing party Sinn Féin's annual conference, press reports. The proposal also aimed to schedule cannabis as a controlled medicinal product and establish a legal framework in the country.25th October 2023
- Ireland: The Citizens' Assembly on Drugs Use held a meeting on 23rd October in which it presented 36 recommendations to the government and the Oireachtas (Irish parliament), including the decriminalisation of drugs for personal use. Possession and consumption of cannabis, regardless of its amount, is currently considered a criminal offence in Ireland.
15th December 2022
Ireland: The Joint Committee on Justice has published a report on an examination of the present approach to sanctions for possession of drugs for personal use. It recommends expanding the Medical Cannabis Access Programme so more sufferers from chronic illness can access cannabis when other treatments have failed to relieve symptoms. On recreational cannabis, it recommends allowing cultivation at non-profit level, in small quantities and for personal use.
24th November 2022
Ireland: Dáil (parliament) member Gino Kenny of the left-wing People Before Profit / Solidarity party today introduced the Misuse of Drugs (Regulation of Cannabis) Bill. If passed, it will mean the possession of up to 7 g of cannabis or 2.5 g of cannabis resin for personal use by anyone aged 18 or over will no longer be a criminal offence.
14th November 2022
- Ireland: On 11th November, the Irish High Court published the ruling we previously reported on concerning the case contesting the zero-tolerance policy for any THC in CBD products in the country. The case was brought by a company that had products imported from Slovenia containing small amounts of THC seized in October 2020. The company argued that, according to the European Court of Justice ruling in the Kanavape case, products with less than 0.2% THC can be manufactured and sold within the EU and cannot be completely banned by member states. The court has rejected the case on the grounds that THC is a controlled drug in Ireland. The judge also said evidence demonstrates the dangers associated with the products and that the present regulatory regime is justified.
10th November 2022
Ireland: The Irish High Court has rejected a case contesting the zero-tolerance policy for any THC in CBD products in the country, press reports. The case was brought by a company which had products imported from Slovenia containing small amounts of THC seized in October 2020. The company argued that, according to the European Court of Justice ruling in the Kanavape case, products with less than 0.2% THC can be manufactured and sold within the EU and cannot be completely banned by member states. The court rejected the case on the grounds that THC is a controlled drug in Ireland. The judge also said the company was “not entitled to an order requiring the Minister for Health to revisit the current restrictions on substances that contain any amount of THC”.
27th October 2022
EU: The Directorate General for Internal Market, Industry, Entrepreneurship and SMEs has told CannIntelligence that some EU member states expressed concerns during the 1st March meeting of the Working Group on Cosmetic Products over the fact that the draft non-paper presenting the European Commission’s preliminary views on the impact of the Kanavape case on the cosmetics sector establishes THC limits. They were worried that existing national legislation might conflict with the establishment of THC thresholds for cosmetic products. Ireland commented during the meeting that “there is no approach to have THC thresholds/limits at national level”, a view supported by Sweden.
7th October 2022
- EU: The minutes of the 1st March 2022 meeting of the Working Group on Cosmetic Products have been published this week. While discussing CBD in cosmetic products, Ireland “commented that ... there is no approach to have THC thresholds/limits at national level”, while Sweden supported Ireland’s position. CBD-Intel is inquiring with the relevant authorities for further clarification, though the statement might refer to the lack of a provision in the draft non-paper allowing member states to establish a THC threshold for CBD in cosmetic products. Sweden considers that a cosmetic product containing THC, regardless of the quantity, is a preparation under the Convention on Psychotropic Substances and therefore considered a “drug”.
26th July 2022
Ireland: The High Court will decide in October whether CBD companies can operate in Ireland, press reports. It follows a series of court proceedings brought by CBD companies whose products have been seized under the Misuse of Drugs Act 1977, which bans products that contain any quantity of THC. They argue that the act is contrary to the European Court of Justice ruling in the Kanavape case.
Market reports
Full-length in-depth reports with detailed data and analysis for individual markets around the world
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Market data
Up-to-date information and insights on brands, pricing and retail across selected markets
Regulatory databases
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
